Bulletin from Moberg Pharma’s Extraordinary General Meeting on December 1[st], 2020
STOCKHOLM, December 1[st], 2020. Moberg Pharma AB (publ)’s (OMX: MOB) (“Moberg Pharma” or the “Company”) Extraordinary General Meeting took place today. The Extraordinary General Meeting resolved as set out below.Approval of the Board of Directors decision on a rights issueThe Extraordinary General Meeting resolved, in accordance with the Board of Directors’ proposal, to approve the Board of Directors’ resolution on 6 November 2020 to issue units consisting of ordinary shares and warrants with preferential rights for the current shareholders in the Company. According the final terms for